Emerging research suggest Retatru tide , a dual activator targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , could offer a significant advancement for weight management . Initial human tests have shown considerable reductions in body mass , possibly exceeding existing body composition therapies . Despite this, more study is nee